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Available online 1 May 2012Abstract OCT4 is a highly conserved gene and plays an important role during early embryonic development and
differentiation. Similar to human OCT4, mouse Oct4 gene generates variants. Oct4A is a master regulator of self-renewal in
pluripotent stem cells. In this study, we have identified a novel Oct4 spliced variant, designated mouse Oct4B, encoding 3
isoforms, termed Oct4B-247aa, Oct4B-190aa and Oct4B-164aa. Furthermore, we have examined the expression pattern of
these isoforms in non-pluripotent cells and their function in somatic cell reprogramming. The results revealed the isoforms
247aa, 164aa localized mainly in nucleus and 190aa expressed dotted in the cytoplasm. In contrast to Oct4A, Oct4B does not
function in somatic reprogramming as that of Oct4A. Taken together, our data for first time described the intact coding
sequence of mouse Oct4B and its function in somatic cell reprogramming. These findings will be important for further analysis
of the epigenetic mechanisms of reprogramming and highlight the necessity of discriminating Oct4 isoforms in future stem cell
research.
© 2012 Elsevier B.V. All rights reserved.Introduction
The transcription factor OCT4 (official symbol POU5F1, also
known as OCT3, OCT3/4, OTF3, and OTF4) is an important
member of OCT protein family, which is well known for its
specific POU DNA binding domain and its diverse function
(Scholer, 1991). The human OCT4 gene encodes three
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doi:10.1016/j.scr.2012.04.004OCT4B and OCT4B1, these spliced variants share the same
domains but have distinct N termini. OCT4A is highly
expressed in the nucleus of compacted embryos and blasto-
cyst, and functions as a main regulator in maintaining the
pluripotency and self-renewal capacities of ES (embryonic
stem) and EG (embryonic germ) cells (Nichols et al., 1998;
Okamoto et al., 1990; Pesce et al., 1998; Rosner et al., 1990);
Abnormal expression of OCT4A will induce the differentiation
of ES cells into endodermal, mesodermal or trophectoderm
cells (Matin et al., 2004; Niwa et al., 2000); OCT4A alone or in
combination with other factors, is able to reprogram the
somatic cells into the progenitor state, indicating an impor-
tant role of OCT4A in the reprogramming process (Cho et al.,
2010; Takahashi and Yamanaka, 2006; Zhao et al., 2009; Zhou
et al., 2009); Recently, some groups have published that
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differentiated cells that have undergone tumorigenesis
(Gazouli et al., 2011; Karoubi et al., 2010).
Compared with OCT4A, human OCT4B encodes a diverse
N terminal domain (NTD), localized mainly in the cytoplasm
of various non-pluripotent cells and somatic cells (Atlasi
et al., 2008). OCT4B cannot sustain ES cell self-renewal,
over expression of OCT4B cannot activate transcription from
OCT4-dependent promoters, although OCT4A did as reported
previously (Lee et al., 2006). In addition, Gao et al., have
described that OCT4B mRNA, containing an internal ribosome
entry site (IRES), could be alternatively translated into at least
three protein isoforms: OCT4B-265aa, OCT4B-190aa and
OCT4B-164aa (Gao et al., 2010; Wang et al., 2009).
OCT4B1 is a newly discovered OCT4 spliced variant,
which is widely expressed in human pluripotent and non-
pluripotent cells. Like OCT4A, OCT4B1 is downregulated in
differentiated cells, suggested that OCT4B1 isoform is a
putative marker for stemness (Gao et al., 2010; Papamichos
et al., 2009).
In mice, Oct4 encodes at least 2 variants, designated
Oct4A and putative Oct4B. Oct4A was detected in somatic
stem cells and has been recognized as a gatekeeper for
maintaining pluripotency in embryonic stem cells and pre-
implantation embryos. However, because of the existence of
pseudogene and misinterpretation of background signals,
the intact open read frame (ORF) and detailed functions of
Oct4B variant remain unclear (Farashahi Yazd et al., 2011;
Mizuno and Kosaka, 2008).
In this study, we identified and characterized a novel
mouse Oct4 transcript variant from ES cells, designated as
mouse Oct4B, whose products share high similarity with
human OCT4B. We demonstrated that the mouse Oct4B can
be translated into three distinct isoforms through endogen-
ous IRES element and alternative initiators of the coding
sequence (CDS). In addition, we have found transcript Oct4B
was not able to reprogram somatic cells to induced
pluripotent stem cells, suggesting it was not involved in
maintaining the pluripotency of stem cells.Results
Identification and Cloning of Mouse Oct4B
As shown in supplementary Fig. 1, more than two Oct4
protein bands were detected in mouse pluripotent cells. Of
note, the 40 kDa protein band represents Oct4A, but other
protein bands (putative Oct4B) were unknown. In an attempt
to identify Oct4B, mouse genome and EST database were
searched for valuable sequence, and based on informative
analysis, we amplified a putative Oct4B sequence from ES
cell cDNA database. It was composed of 741 base pair,
encoding 247 amino acids (supplementary Tab. 2 and 3), and
was highly similar to human OCT4B (87% identities, Fig. 4B).
After transfection with Oct4B transcript, three different
protein products were detected, with molecular mass of
approximately 30 kDa, 23 kDa and 20 kDa (Fig. 1B). The
30 kDa protein was the product of Oct4B full-length CDS
(247aa), whereas the other two bands needed further
validation.Identification of the Putative IRES Element in Oct4B
mRNA
Generally, it is known that a single mature mRNA can be
translated into a unique protein product, however, with the
help of endogenous internal ribosome entry site (IRES), some
mRNAs are capable of producing more than two isoforms from
the same transcript (Gao, et al., 2010; Wang et al., 2009). Due
to Oct4B generated three isoforms (30 kDa, 23 kDa and 20 kDa),
therefore we supposed that the coding sequence (CDS) of Oct4B
contain internal ribosome entry site (IRES) element. In order to
test this hypothesis, bicistronic plasmid RFP-pQCXIN(IRES)-GFP
was utilized. As schematic structure shown in Fig. 2A, RFP-
pQCXIN(IRES)-GFP is characterized by the existence of two
tandem ORFs of RFP and GFP, which is linked by candidate
sequence. Generally, the green fluorescent protein could not
be translated unless the inserted sequence contains IRES
element. In this study, the IRES sequence of the bicistronic
vector was replaced with target sequence (1-171nt of Oct4B) of
the mouse Oct4B CDS, followed by transfection into NIH3T3
cells. The results showed (Fig. 2B) after nt 1–117 was
introduced in plasmid, GFP expression was observed. Thus this
117-bp fragment at position 1–117 exhibited the IRES activity.
Therefore, a putative IRES element was identified in mouse
Oct4B mRNA.
Identification of the Oct4B Translation Initiation
Codons by Site-Directed Mutagenesis
IRES-mediated translation can be initiated in an internal
region of the mRNA, resulting in alternative initiation of
translation and protein isoforms formation (Macejak and
Sarnow, 1991). In eukaryotes, ATG is the dominant initiation
codon, but there exist other codons which can initiate
translation (Arnaud et al., 1999; Nanbru et al., 1997; Vagner
et al., 1995). Because of the existence of additional isoforms
and IRES element, we hypothesized that mouse Oct4B could
use different initiation codons in a single mRNA to encode
three protein isoforms. To find out these alternative initiation
codons, potential site-directedmutagenesis were induced and
followed by identification of their protein products. The
results revealed that mutation of CTG (Leucine) to CTT
(Leucine) at position 172–174 exclusively abolished the
synthesis of 23 kDa product of Oct4B, this result demonstrated
that the CTG at 172–174 encoding an isoform of Oct4B
containing 190 amino acids; and direct mutagenesis of
250–252 ATG (Methionine) to ATT (Isoleucine) abolished the
synthesis of the 20 kDa protein band but not the 30 and 23 kDa
protein bands (Figs. 2C, D), thus this result supported that the
20 kDa isoform was synthesized at 250-252nt ATG codon and it
contained 164 amino acids. In conclusion, a singleOct4BmRNA
could encode three isoforms: Oct4B-247aa (AUG-initiated
isoform encoding 247 amino acids), Oct4B-190aa (CTG-
initiated isoform encoding 190 amino acids), and Oct4B-
164aa (AUG-initiated isoform encoding 164 amino acids).
Subcellular Localization of Oct4B Isoforms
Most alternative initiation of translation regulates the
subcellular localization of protein isoforms and the sub-
location of protein reflects its corresponding functions
Figure 1 Identification of mouse Oct4B transcript. (A): The amplification product of Oct4B coding sequence (CDS). M: DNA marker
DL2000. (B): Protein expression of Oct4B. The CDS of Oct4B was inserted into pQCXIP plasmid and transfected into 293 T cells,
Western Blot was used to check the protein products. Results revealed Oct4B transcript translates three isoforms: 30 kDa, 23 kDa and
20 kDa; pQCXIP-GFP was transfected as negative control. (C): The structure of the pQCXIP plasmid. (D): Schematic structure of mouse
Oct4 transcripts. The alternative splicing boxes are shown in black and grey colors.
71A novel variant of Oct3/4 gene was found in mouse embryonic stem cells.(Land and Rouault, 1998). As we shown mouse Oct4B encodes
3 isoforms (Oct4B247aa, Oct4B190aa and Oct4B164aa), though
with different length of N-termini, they share the same POU
domain, C-termini domain (CTD) and nuclear localization signal
(RKRKR) in the domain (Fig. 4A). To investigate the localization
of different Oct4 isoforms, we constructed variant expressionFigure 2 Identification of a putative IRES element in mouse O
bicistronic plasmid. (B): NIH3T3 cells were transfected with bicistro
Live Cell Imaging System with 490 nm and 537 nm wavelength respec
1–171 nt of Oct4B CDS. An 80nt random sequence was utilized as
putative initiation sites were shown: position 172–174 CTG (Leucine
mutated to ATT (Isoleucine). (D): Western Blot analysis of site-dir
vectors: pQCXIP-172-174 and pQCXIP-250-252. pQCXIP-GFP was tran
mutation. Lane 2: mutation of CTG to CTT at 172–174 site. Lane 3: m
5: 293 T cells.plasmids fused with GFP protein (Fig. 3A), and Live Cell Image
System was used to monitor the distribution of these isoforms.
The results turned out that although three isoforms diffuse both
in the nucleus and cytoplasm, isoforms Oct4B-247aa and Oct4B-
164aa mainly distributed in the nucleus, whereas Oct4B-190aa
expressed dotted in the cytoplasm (Fig. 3B), suggesting Oct4B-ct4B CDS. (A): Schematic structure of RFP-pQCXIN(IRES)-GFP
nic plasmids, RFP and GFP expression were watched under the
tively. The IRES element of bicistronic vector was replaced with
the negative control. (C): Partial sequence of Oct4B CDS. The
) was mutated to CTT (Leucine); 250–252 ATG (Methionine) was
ected mutagenesis. 293 T cells were transfected with mutated
sfected as negative control. Lane 1: pQCXIP-Oct4B, without any
utation of ATG to ATT at 250–252 site. Lane 4: pQCXIP-GFP. Lane
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Oct4B-164aa.The Effects of Oct4B on the Reprogramming of
Somatic Cells
Recent discoveries in the field of stem cell biology have led
to the ability to reprogram somatic cells to pluripotent state
in mammals, these cells are termed induced pluripotent
stem cells (iPSCs), which have the identical developmental
potential as ES cells. This new approach allows the derivation
of patient-specific cell lines from individuals with specific
diseases (Birgitt Schule., 2011), therefore, it can provide
great potential benefits for regenerative medicine (Takahashi
and Yamanaka, 2006). As we known, Oct4A is the key factor in
the process of iPSC induction. The mouse Oct4B protein shares
the same functional POU and CTD domainwith Oct4A, with the
exception of a diverse NTD. To study the role of Oct4B in the
process of somatic cell reprogramming, we introduced Oct4B,
Sox2, Klf4 and c-Myc into mouse embryonic fibroblast (MEFs)
by retroviral transduction. After 14 days of consecutive
culture, the infected cells were fixed and stainedwith alkaline
phosphatase (AP staining). However, instead of becoming ES-
like clones, infected cells died gradually with the extension of
culture time and no positive clones emerged from the Oct4B
infected group, whereas in the positive control group
(infected with Oct4A, Sox2, Klf4 and c-Myc), more than 105
AP staining positive clones were counted (Fig. 4C, supplemen-
tary Fig. 2 and 3). These results suggest that Oct4B is not a
functional factor in the process of reprogramming as Oct4A
do.
Of note, many IRES-containing mRNAs encode proteins
that play important roles in development, cell cycle
progression, cell apoptosis and stress response (Prats and
Prats, 2002; Stoneley et al., 2000). Mouse Oct4B has IRES
element and encodes variants. To investigate whether the
expression level of Oct4B would be altered under unfavor-
able conditions, ES cells (R1) were cultured in hyperpyrexia
and hyperxia conditions respectively. Results revealed that
under stress conditions, Oct4B-190aa expression was
detected upregulated gradually over time (Fig. 5), so it
seemed isoform Oct4B-190aa was involved in stress response
and maybe act as an anti-stresses protein for the existence
of endogenous IRES element.Figure 3 Distribution of mouse Oct4B isoforms. (A): Schematic
structure of expression plasmid pcDNA3.1-GFP. Isoforms of
Oct4B-247aa, 190aa, 164aa were each fused with GFP and
transfected into NIH3T3 cells. After 28 hours, fluorescence
expression was observed by Live Cell Imaging System under
490 nm wavelength and photos were taken. (B): The subcellular
distribution of Oct4B-247aa, Oct4B-190aa, and Oct4B-164aa.
GFP was used as the control.Discussion
Mouse embryonic stem (mES) cells are an immensely power-
ful tool for studying the early differentiation of mammalian
cell lineages and regenerative medicine. Oct4A is the key
regulator in maintaining ES cells pluripotency and self-
renewal. However, because of pseudogene expression and
alternative splicing, mouse Oct4 variants are still a con-
troversial and unsolved issue (Farashahi Yazd, et al., 2011;
Mizuno and Kosaka, 2008). In this study, we clearly
demonstrated the existence of Oct4B transcript in ES cells
and found that Oct4A and Oct4B have different function in
reprogramming of somatic cell to iPSC and self-renewal,
therefore, it is necessary to distinguish Oct4A and Oct4B
variants in future research.First of all, we identified the coding sequence of Oct4B
transcript, which contained 741 base pairs and encoded 247
amino acids (supplementary Tab.2 and 3). The mouse Oct4A
gene is known to encode 353 amino acids and encompass 5
Figure 4 The features and functions of Oct4B. (A): Schematic representation of mouse Oct4 isoforms. (B): The identities of human
OCT4B and mouse Oct4B proteins. (C): The alkaline phosphatase (AP) staining of infected mouse fibroblasts after 14 days of
consecutive culture. Fibroblasts were infected with two groups of retrovirus: Oct4A, Sox2, Klf4, c-Myc and Oct4B, Sox2, Klf4, c-Myc,
pMX-GFP was infected as negative control.
73A novel variant of Oct3/4 gene was found in mouse embryonic stem cells.exons, whereas mouse Oct4B is composed of 4 exons: exon 1
contains exon 2 and 66nt of intron 1 of Oct4A, exon 2, 3 and
4 are exactly the same with exon 3, 4 and 5 of Oct4A CDSFigure 5 The expression level of Oct4B-190aa under stress conditi
H2O2 (B, D) with different time course, Western Blot analysis was used
under heat shock treatment. (D): The relative expression of Oct4B-19(Fig. 1D). Due to the similar nucleic acid sequence between
Oct4A and Oct4B, therefore, primers should be designed in
distinctive regions when using PCR analysis: to detect theons. ES cells (R1) were treated with either 42°C (A, C) or 800 uM
the check the results. (C): The relative expression of Oct4B-190aa
0aa under oxidative stress treatment.
74 C. Guo et al.expression level of Oct4A, primers should be set in the exon
1 of Oct4A, whereas the 66 bp at 5` end of Oct4B should be
included when detecting Oct4B transcript.
Similar to human OCT4B, the mouse Oct4B transcript
generates three isoforms: Oct4B-247aa (full-length), Oct4B-
190aa, and Oct4B-164aa. The protein sequences of these
isoforms are highly identical between mouse and human.
Oct4B-247aa is the longest product, it's synthesized started
from the first ATG initiation site. Compared with the mouse
Oct4A, Oct4B-247aa consists of an identical POU domain and
C-termini and with different NTD (Fig. 4A). Although Oct4B-
190aa shares the same mRNA with Oct4B-247aa, the transla-
tion was initiated by another start codon CUG (172–174
position) under the mediation of IRES (1-171nt) element.
Oct4B-164aa is the shortest isoform, and the translation was
initiated by ATG (250–252 position) codon. Compared with
Oct4A, products Oct4B-190aa and 164aa contain intact C-
termini and partial POU domain without NTD, so it seems they
are not functional copies of the Oct4 protein. Although these
three isoforms are generated from a single Oct4B mRNA, the
endogenous protein isoforms may not be simultaneously
expressed in the same cell type, the expression of each
isoform may depend on its function and the cell state (Mizuno
and Kosaka, 2008). And due to the absence of distinctive
primer sequence, Western Blot but not PCR should be the
optimal method to distinguish these isoforms.
Combined with Sox2, Klf4 and c-Myc, Oct4B was not able
to reprogram somatic cell to iPSC as that of Oct4A, although
it contains an identical POU domain and CTD to Oct4A, and
this may attributed to the difference of NTD. Human OCT4A
protein contains three domains: the N terminal domain
(NTD, 1-133aa), encompassing a transcriptional activation
region that is active in various cultured cell types; the POU
DNA-binding domain (134aa–289aa) that binds to DNA in a
sequence-specific fashion, which is essential for its proper
function in ES cells (Niwa et al., 2002); and the C terminal
domain (CTD, 290aa-362aa) which controls the transactiva-
tion function of OCT4 in a cell type-specific way (Brehm et
al., 1997). Yet the activity of these two transactivation
domains is not identical in ES cells, the NTD domain has a
specific function to transactivate a suite of target genes
independently of interaction with partners such as Sox2 or
cellular E1A-like factors (Niwa, et al., 2002). OCT4A binds its
target sequences by the recognition of POU domain and
octamer motif (5`-ATGCAATG-3`), and then transactivates
the downstream genes with the assistance of the NTD or CTD
domain, thus maintaining pluripotency or initiating cell
differentiation (Cauffman et al., 2006; Niwa, et al., 2002;
Takeda et al., 1992). Compared with OCT4A, human OCT4B
shares the conserved POU and CTD domains, but lacks the
transactivation domain of the NTD. Moreover, amino acids
1–20 and 21–40 of the NTD have an inhibitory effect on the
binding of OCT4B POU domain and target sequence (Lee, et
al., 2006). However, overexpression of OCT4B does not
interfere with the transactivation reaction activated by
OCT4A, and so OCT4B has no effect on pluripotency (Lee, et
al., 2006). The mouse Oct4B NTD is composed of 24 amino
acids and has no similarity with that of Oct4A. However, it
shares a high identity with the human OCT4B: the peptides
1-11aa and 12-23aa of mouse Oct4B are exactly the same as
1-11aa and 29-40aa of human OCT4B NTD which inhibits the
transactivation of the POU domain (Fig. 4B). Based on thissimilarity, it is likely that the 1-23aa of the mouse Oct4B
interrupts the binding of the POU domain with target
sequence and thus prevents the activation of downstream
signal pathways.
There exist two different known mechanisms of protein
synthesis from mRNA template: cap-dependent and cap-
independent translation initiation. The latter is driven by
IRES element that was found in both viral RNAs and cellular
mRNAs (Balvay et al., 2009; Shatsky et al., 2010). IRES
element was originally discovered in the picornaviral RNA
translation process. Viral RNA folds into specific RNA
structure to mimic the ribosome scaffold and then recruits
ribosomal subunits and translational factors, subsequently
starts the elongation process. With reduction of protein
involvement and less steps, cap-independent translation
dominates when the canonical cap-dependent pathway is
interrupted (Fernandez-Miragall et al., 2009; Jackson,
2005). IRES-mediated translation represents a cellular
“backup” pool, leading to cell survival or cell death under
unfavorable conditions and it confers a regulation mechan-
ism of selective translation at the posttranscriptional level.
And this process makes cell respond quickly to rapid changes
(Komar & Hatzoglou, 2005; Kozak, 2005). In concordance
with other reports (Cheng et al., 2007; Farashahi Yazd, et
al., 2011; Karoubi, et al., 2010; Mizuno and Kosaka, 2008),
in this study, we illustrated Oct4B-190aa mainly expressed
in cytoplasma, although it had nuclear localization signal in
POU domain, and the underlying mechanism still need to be
further investigated. Meanwhile Oct4B-190aa expression
level was upregulated under heat shock and oxidative
conditions, suggesting that it was involved in the stress
response activity.
In conclusion, mouse Oct4 gene, regulated by alternative
RNA splicing, endogenous IRES element and alternative
translation initiation at the posttranscriptional level, may
generates 4 isoforms with different function. All of these
characteristics of Oct4 contribute to the complexity of its'
study. This work highlights the significance of differentiating
the expression pattern and biological functions of Oct4
variants.
Materials and methods
Blast and search of mouse Oct4B coding sequence
(CDS)
Potential mouse Oct4B sequences were searched on NCBI
EST database and UCSC database (http://genome.ucsc.edu/).
Primers were designed for any candidate EST and amplified by
PCR (supplementary Tab. 1).
Cell culture and DNA transfection
Mouse embryonic stem cells (R1) were grown as described
previously (Nagy et al., 1993). Briefly, cells were cultured in
Dulbecco`s modified Eagle`s medium (DMEM) with 15%
Gibco fetus bovine serum (FBS), 1 mM L-glutamine, 1%
nonessential amino acids, 0.1 mM β-mercaptoethanol,
100U/ml streptomycin/penicillin, and 1000U/ml LIF on
mitomycin C treated mouse embryonic fibroblast feeders in
humidified atmosphere at 37°C with 5% CO2. When grown
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removed for further researches. 293 T and NIH3T3 cells were
cultured in DMEM with 10% FBS and transfected with
Lipofectamine 2000 (Invitrogen) according to the manufac-
turer's instructions. After 36 hours, cells were harvested for
further assays. To identify the protein expression and
subcellular localization, photos were taken with Leica
DMIRE2 Live Cell Imaging System directly at 490 nm and
537 nm wavelength respectively.
Total RNA extraction and RT-PCR
Total RNA was extracted from cells using Trizol reagent
(Invitrogen, Carlsbad, CA). Total RNA was treated with RNase-
free DNase I (Invitrogen) to remove any DNA contamination.
Reverse transcriptionwas carried out with 1 μg total RNA using
SuperScript III (Invitrogen). RT-PCR was carried out with
primerstar HS DNA polymerase according to the instructions
(Takara Company). Products were cloned into T vector and
more than 10 positive clones were picked and sequenced.
Plasmids construction
Site-directed mutation PCR were performed using primerstar
HS DNA polymerase with optimized primers (supplementary
Tab. 1). Products were digested with DpnI enzyme for 1 hour
at 37°C and then transformed into JM109. Correct clones were
picked through sequencing and subcloned into expression
vector pQCXIP (Cat. No. 631514, Clontech Company). To find
out the potential IRES sequence, various N terminal lengths of
Oct4B sequence were amplified and cloned into bicistronic
vector RFP-pQCXIN(IRES)-GFP, 293 T cells were transfected to
examine the effect. Green fluorescent protein (GFP) was
fused with Oct4B and its isoforms to detect their distributions.
All of the plasmids were sequenced to verify their structure
and open reading frames.
Western blot analysis
Total proteins were extracted by RIPA buffer (50 mM Tris,
pH7.6, 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40) supple-
mented with 1 mM PMSF, and Western Blot analysis was
performed using anti-oct4 antibodies: N-19 was used to
recognize Oct4A, Oct4B, Oct4B-190 (1:1000, sc-8628, Santa
Cruz Biotechnology); ab19857 was used to recognize Oct4B-
164 (1:1000, Abcam Company). The anti-α-tubulin antibody
(1:2000, Sigma St Louis) was used as a normalizing control. The
reactive bands were detected by chemiluminescence using
western lightening (Thermo Company).
The functions of mouse Oct4B
pMXs retroviral vectors-Oct4A, Sox2, Klf4, c-Myc, GFP were
purchased from Addgene (http://www.Addgene.org), and the
induced pluripotent stem cell (iPS) was done as described
previously. Briefly (Takahashi et al., 2007), plasmids (pMXs
retroviral vectors-Oct4A, Sox2, Klf4, c-Myc and pMX-GFP, per
10ug) were tranfected into 8×106 Plat-E packaging cells. 36
hours and 72 hours later retrovirus were collected and filtered
through 0.45um cellulose acetate filter respectively. 2×105mouse embryonic fibroblast cells (MEF) were infected for 6
hours supplemented with 5ug/ml polybrene, then the medium
was changed to R1 medium for consecutive culture. At the
14th day after infection, cells were fixed with 4% polyox-
ymethylene and stained with alkaline phosphatase (AP) kit. R1
cells were treated with 42°C and 800uM H2O2 separately,
proteins were collected at 0.5 hour, 1 hour, 1.5 hours, and 2
hours after treatment, Western Blot was used to observe the
expression of Oct4B.Acknowledgments
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